Evidence map›Paper›PMID 36337708›Full record

ArticleFrontiers in aging neuroscience2022

Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints.

Mar Ariza, Neus Cano, Bàrbara Segura, Ana Adan, Núria Bargalló, Xavier Caldú, Anna Campabadal, Maria Angeles Jurado, Maria Mataró, Roser Pueyo and 7 more

3 registry-linked trialsAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05307549 completednot on this map

COVID-19 and Brain: Cognition and Mental Health

TypeobservationalSponsorUniversity of BarcelonaRan2021 to 2022Enrolled200ConditionsCOVID-19
NCT05307575 completednot on this map

Cognition, Emotion/Behavior, Functionality and Brain Connectivity in Recovered COVID-19 Patients

TypeobservationalSponsorConsorci Sanitari de TerrassaRan2021 to 2024Enrolled630ConditionsPost-COVID Syndrome
NCT06042530 unknown statusnot on this map

Cognitive Impairment and Fatigue After Mild to Moderate COVID-19 - Relation to Biomarkers and Neuronal Network Functions

TypeobservationalSponsorDanderyd HospitalRan2021 to 2025Enrolled100ConditionsPost COVID-19 Condition, Cognitive Impairment, Fatigue, MentalArmsNeuropsychological investigation, Optometric investigation, Magnetic Resonance Imaging, Immunological biomarkers
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Episodic memory deficits and processes in post-COVID condition.European archives of psychiatry and clinical neuroscience · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mar ArizaMedical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
Neus CanoMedical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
Bàrbara SeguraMedical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
Ana AdanInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.
Núria BargallóInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Xavier CaldúInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.
Anna CampabadalMedical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
Maria Angeles JuradoInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.
Maria MataróInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.
Roser PueyoInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.
Roser Sala-LlonchInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.
Cristian BarruéDepartment of Computer Science, Universitat Politècnica de Catalunya - BarcelonaTech, Barcelona, Spain.
Javier BejarDepartment of Computer Science, Universitat Politècnica de Catalunya - BarcelonaTech, Barcelona, Spain.
Claudio Ulises CortésDepartment of Computer Science, Universitat Politècnica de Catalunya - BarcelonaTech, Barcelona, Spain.
NAUTILUS-Project Collaborative Group
Carme JunquéMedical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
Maite GaroleraClinical Research Group for Brain, Cognition and Behavior, Consorci Sanitari de Terrassa (CST), Terrassa, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most prevalent symptoms of post-COVID condition is cognitive impairment, which results in a significant degree of disability and low quality of life. In studies with large sample sizes, attention, memory, and executive function were reported as long-term cognitive symptoms. This study aims to describe cognitive dysfunction in large post-COVID condition individuals, compare objective neuropsychological performance in those post-COVID condition individuals with and without cognitive complaints, and identify short cognitive exams that can differentiate individuals with post-COVID symptoms from controls. To address these aims, the Nautilus project was started in June 2021. During the first year, we collected 428 participants' data, including 319 post-COVID and 109 healthy controls (18-65 years old) from those who underwent a comprehensive neuropsychological battery for cognitive assessment. Scores on tests assessing global cognition, learning and long-term memory, processing speed, language and executive functions were significantly worse in the post-COVID condition group than in healthy controls. Montreal Cognitive Assessment, digit symbol test, and phonetic verbal fluency were significant in the binomial logistic regression model and could effectively distinguish patients from controls with good overall sensitivity and accuracy. Neuropsychological test results did not differ between those with and without cognitive complaints. Our research suggests that patients with post-COVID conditions experience significant cognitive impairment and that routine tests like the Montreal Cognitive Assessment, digit symbol, and phonetic verbal fluency test might identify cognitive impairment. Thus, the administration of these tests would be helpful for all patients with post-COVID-19 symptoms, regardless of whether cognitive complaints are present or absent. Study registration: www.ClinicalTrials.gov, identifiers NCT05307549 and NCT05307575.

Indexed as

cognitive functionCOVID-19NeuroCOVIDneuropsychological testpost-COVID-19 condition

Identifiers

PMID36337708
PMCPMC9631485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.